Natural Product: NPC579730

Natural Product IDNPC579730
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
8-hydroxy-3-(4-methoxyphenyl)-7-[(2~{S},3~{R},4~{S},5~{S},6~{R})-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
IUPAC Name 8-hydroxy-3-(4-methoxyphenyl)-7-[(2~{S},3~{R},4~{S},5~{S},6~{R})-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey CJPPXZWWEOEKFP-IWLDQSELSA-N
Standard InCHI InChI=1S/C22H22O10/c1-29-11-4-2-10(3-5-11)13-9-30-21-12(16(13)24)6-7-14(18(21)26)31-22-20(28)19(27)17(25)15(8-23)32-22/h2-7,9,15,17,19-20,22-23,25-28H,8H2,1H3/t15-,17-,19+,20-,22-/m1/s1
SMILES COC1=CC=C(C2=COC3=C(O)C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)=CC=C3C2=O)C=C1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   446.12 Volume:   421.653
?
Van der Waals volume.
Dense:   1.058 LogP:   0.9
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.612
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.941
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   5.0 Rigid Bonds:   24.0
TPSA:   159.05
?
Topological Polar Surface Area.
H-Bond Acceptor:   10.0
H-Bond Donor:   5.0 Rings:   4.0
Heavy Atoms:   10.0

MedChem Properties

QED Drug-Likeness Score:   0.37 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.769 Fsp3:   0.318
MCE-18:   83.621
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.559 Fluc inhibitor:   0.719
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.943
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.668
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.16 Promiscuous compounds:   0.235

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.21 MDCK Permeability:   -5.326
Pgp-inhibitor:   0.001 Pgp-substrate:   0.048
PAMPA:   0.976
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.957
20% Bioavailability (F20%):   0.166 30% Bioavailability (F30%):   0.93
50% Bioavailability (F50%):   0.921

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.009 MRP1:   0.081
Plasma Protein Binding (PPB):   81.069% Volume Distribution (VD):   -0.094
Fu: 19.327%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.14
BSEP inhibitor:   0.005

ADMET: Metabolism

CYP1A2-inhibitor:   0.285 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.018
CYP2C9-inhibitor:   0.065 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.005 CYP2D6-substrate:   0.001
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.001
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.962
HLM stability:   0.001
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.556 Half-life (T1/2):  2.917

ADMET: Toxicity

hERG Blockers:  0.059 hERG Blockers (10um):  0.141
Human Hepatotoxicity (H-HT):  0.718 Drug-induced Liver Injury (DILI):  0.981
AMES Toxicity:  0.918 Rat Oral Acute Toxicity:  0.064
Maximum Recommended Daily Dose:  0.068 Skin Sensitization:  0.96
Carcinogencity:  0.452 Eye Corrosion:  0.0
Eye Irritation:  0.193 Respiratory Toxicity:  0.036
Drug-induced Neurotoxicity:  0.038 Ototoxicity:  0.93
Hematotoxicity:  0.508 Drug-induced Nephrotoxicity:  0.817
Genotoxicity:  0.702 RPMI-8226 Immunitoxicity:  0.127
A549 Cytotoxicity:  0.247 Hek293 Cytotoxicity:  0.238
BCF:   0.45
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.247
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.684
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.931
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20312 Pterocarpus marsupium Species Fabaceae Eukaryota n.a. heartwood n.a. DOI[10.1021/np50031a029]
NPO20312 Pterocarpus marsupium Species Fabaceae Eukaryota n.a. bark n.a. DOI[10.1021/np50031a029]
NPO20312 Pterocarpus marsupium Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[8377021]
NPO20312 Pterocarpus marsupium Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[9214733]
NPO20312 Pterocarpus marsupium Species Fabaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO20312 Pterocarpus marsupium Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO20312 Pterocarpus marsupium Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO20312 Pterocarpus marsupium Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC579730 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7333 Intermediate Similarity NPC45165
0.7143 Intermediate Similarity NPC603782
0.6883 Remote Similarity NPC135345
0.679 Remote Similarity NPC229729
0.6709 Remote Similarity NPC258035
0.6618 Remote Similarity NPC333691
0.65 Remote Similarity NPC161749
0.642 Remote Similarity NPC73511
0.6098 Remote Similarity NPC105511
0.6098 Remote Similarity NPC156457
0.5814 Remote Similarity NPC601607
0.5765 Remote Similarity NPC100720
0.5747 Remote Similarity NPC307518
0.5679 Remote Similarity NPC25547
0.5581 Remote Similarity NPC205076
0.5529 Remote Similarity NPC197896
0.5529 Remote Similarity NPC313163
0.5517 Remote Similarity NPC479402
0.5517 Remote Similarity NPC479401
0.5513 Remote Similarity NPC41844
0.5506 Remote Similarity NPC479407
0.5412 Remote Similarity NPC211014
0.5405 Remote Similarity NPC610981
0.5349 Remote Similarity NPC234739
0.5333 Remote Similarity NPC48773
0.5227 Remote Similarity NPC138540
0.5222 Remote Similarity NPC607201
0.519 Remote Similarity NPC78809
0.5172 Remote Similarity NPC95090
0.5172 Remote Similarity NPC27408
0.5169 Remote Similarity NPC481043
0.5169 Remote Similarity NPC224462
0.5155 Remote Similarity NPC51326
0.5152 Remote Similarity NPC235575
0.5116 Remote Similarity NPC160515
0.5114 Remote Similarity NPC186807
0.5057 Remote Similarity NPC259070
0.5057 Remote Similarity NPC58053
0.5055 Remote Similarity NPC479406

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC579730 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7568 Intermediate Similarity NPD3818 Discontinued
0.65 Remote Similarity NPD4381 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data